Stay tuned for our LIVE OncLive News Network coverage straight from the #ASH18 conference floor! 

Dr. Feldman on Link Between Obesity and Risk for RCC

Adam Feldman, MD
Published: Thursday, Jul 09, 2015



Adam S. Feldman, MD, MPH, urologist, Department of Urology, Massachusetts General Hospital, discusses the association between obesity and the risk of developing total and fatal renal cell carcinoma (RCC).

In a study, researchers examined obesity to determine if it was a risk factor for developing RCC, as well as fatal RCC. This has been debatable in previous studies, Feldman explains, as obesity was not found to be a risk factor for developing the disease. However, researchers used longitudinal data of patients’ BMI to calculate their risk for obesity.

It was found that obesity is a risk factor for RCC. Results also suggested that obesity is adversely associated with risk of fatal RCC, though these data were not statistically significant.
 


Adam S. Feldman, MD, MPH, urologist, Department of Urology, Massachusetts General Hospital, discusses the association between obesity and the risk of developing total and fatal renal cell carcinoma (RCC).

In a study, researchers examined obesity to determine if it was a risk factor for developing RCC, as well as fatal RCC. This has been debatable in previous studies, Feldman explains, as obesity was not found to be a risk factor for developing the disease. However, researchers used longitudinal data of patients’ BMI to calculate their risk for obesity.

It was found that obesity is a risk factor for RCC. Results also suggested that obesity is adversely associated with risk of fatal RCC, though these data were not statistically significant.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x